Alnylam Pharmaceuticals
ALNY
#1131
Rank
ยฃ15.50 B
Marketcap
ยฃ115.78
Share price
-1.11%
Change (1 day)
-65.55%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

EPS for Alnylam Pharmaceuticals (ALNY)

EPS in 2023 (TTM): -ยฃ3.29

According to Alnylam Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is ยฃ14.81. In 2022 the company made an earnings per share (EPS) of -ยฃ6.95 a decrease over its 2021 EPS that were of -ยฃ5.38.

EPS history for Alnylam Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ3.29-52.58%
2022-ยฃ6.9529.03%
2021-ยฃ5.38-3.36%
2020-ยฃ5.57-8.48%
2019-ยฃ6.097.67%
2018-ยฃ5.6539.74%
2017-ยฃ4.0412.94%
2016-ยฃ3.5838.84%
2015-ยฃ2.58-32.88%
2014-ยฃ3.84259.44%
2013-ยฃ1.07-31.25%
2012-ยฃ1.5552.94%
2011-ยฃ1.0230.77%
2010-ยฃ0.78-8.77%
2009-ยฃ0.8578.12%
2008-ยฃ0.48-70.78%
2007-ยฃ1.6499.09%
2006-ยฃ0.82-43.88%
2005-ยฃ1.47-82.33%
2004-ยฃ8.29-59.23%
2003-ยฃ20.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
ยฃ3.92-73.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ1.42-90.39%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
ยฃ31.33 111.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-ยฃ1.97-113.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-ยฃ0.55-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-ยฃ0.06728-100.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-96.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
-ยฃ2.49-116.81%๐Ÿ‡บ๐Ÿ‡ธ USA